期刊
ANNALS OF ONCOLOGY
卷 17, 期 -, 页码 V148-V152出版社
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdj971
关键词
pancreatic cancer; EGFR inhibitor; farnesyl transferase inhibitor; COX-2 inhibitor
类别
The recent elucidation both of the mechanisms involved in pancreatic cancer carcinogenesis and the related molecular events, has led to several distinct therapeutic advances, including many novel target agents, such as monoclonal antibodies against EGFR, EGFR-tyrosine kinase inhibitors, monoclonal antibody against VEGF, farnesyl transferase inhibitors, matrix metalloproteinase inhibitors, COX 2 inhibitors, and the development of gene therapy to target pancreatic cancer. This review highlights recent findings in the treatment of pancreatic cancer by using these novel therapeutic approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据